Slate: Everything, Um, Unusual About Kodak’s Trump-Assisted Pivot to Pharmaceuticals

Slate: Everything, Um, Unusual About Kodak’s Trump-Assisted Pivot to Pharmaceuticals. “Kodak’s stock peaked as high as $60, and investors traded 272 million of its shares on Wednesday, up from its previous daily average trading volume of 125,000. Much of this activity came from day traders using the investing platform Robinhood. Before Trump’s announcement on Tuesday, approximately 9,300 Robinhood users had Kodak in their portfolios; by noon on Wednesday, that number rose to more than 72,000. Many financial analysts are warning, however, that a lot of things don’t quite add up about Kodak’s sudden bout of success on the stock market. Taken all together, this week has been a particularly fishy Kodak moment.”

Leave a Reply